Q32 Bio (QTTB) Cash from Investing Activities (QoQ) (2017 - 2024)
Q32 Bio (QTTB) Cash from Investing Activities (QoQ) (2017 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Q32 Bio |
167.59 Mn |
116.84 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
-100.02% |
| Sep 30, 2024 |
0.55% |
| Jun 30, 2024 |
10,093.81% |
| Sep 30, 2023 |
-200.00% |
| Jun 30, 2023 |
120.00% |
| Mar 31, 2023 |
-100.03% |
| Dec 31, 2022 |
116.62% |
| Sep 30, 2022 |
-161.59% |
| Jun 30, 2022 |
-124.58% |
| Mar 31, 2022 |
285.50% |
| Dec 31, 2021 |
865.10% |
| Sep 30, 2021 |
132.93% |
| Jun 30, 2021 |
83.88% |
| Mar 31, 2021 |
-8,825.13% |
| Dec 31, 2020 |
-102.46% |
| Sep 30, 2020 |
-25.31% |
| Jun 30, 2020 |
-54.77% |
| Mar 31, 2020 |
674.21% |
| Dec 31, 2019 |
-52.45% |
| Sep 30, 2019 |
65.70% |
